Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

INTRODUCTION: COSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Clin Trials Commun
Main Authors: Nunn, Andrew, Anywaine, Zacchaeus, Seeley, Janet, Munderi, Paula, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Abaasa, Andrew, Grosskurth, Heiner
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918030/
https://ncbi.nlm.nih.gov/pubmed/27536738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2016.05.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados